- Home
- AMBC vs FTRE Comparison
AMBC vs FTRE Comparison
Compare AMBC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- FTRE
- Stock Information
- Founded
- AMBC 1971
- FTRE 1996
- Country
- AMBC United States
- FTRE United States
- Employees
- AMBC N/A
- FTRE N/A
- Industry
- AMBC Property-Casualty Insurers
- FTRE Medical Specialities
- Sector
- AMBC Finance
- FTRE Health Care
- Exchange
- AMBC Nasdaq
- FTRE Nasdaq
- Market Cap
- AMBC 411.3M
- FTRE 469.0M
- IPO Year
- AMBC 1991
- FTRE N/A
- Fundamental
- Price
- AMBC $6.76
- FTRE $5.32
- Analyst Decision
- AMBC Strong Buy
- FTRE Hold
- Analyst Count
- AMBC 1
- FTRE 11
- Target Price
- AMBC $15.00
- FTRE $17.10
- AVG Volume (30 Days)
- AMBC 1.1M
- FTRE 2.7M
- Earning Date
- AMBC 08-04-2025
- FTRE 08-11-2025
- Dividend Yield
- AMBC N/A
- FTRE N/A
- EPS Growth
- AMBC N/A
- FTRE N/A
- EPS
- AMBC N/A
- FTRE N/A
- Revenue
- AMBC $253,912,000.00
- FTRE $2,685,600,000.00
- Revenue This Year
- AMBC N/A
- FTRE N/A
- Revenue Next Year
- AMBC $17.41
- FTRE $1.36
- P/E Ratio
- AMBC N/A
- FTRE N/A
- Revenue Growth
- AMBC 125.08
- FTRE N/A
- 52 Week Low
- AMBC $5.99
- FTRE $3.97
- 52 Week High
- AMBC $13.64
- FTRE $28.41
- Technical
- Relative Strength Index (RSI)
- AMBC 38.39
- FTRE 49.95
- Support Level
- AMBC $6.65
- FTRE $3.97
- Resistance Level
- AMBC $7.18
- FTRE $6.56
- Average True Range (ATR)
- AMBC 0.35
- FTRE 0.49
- MACD
- AMBC -0.05
- FTRE 0.10
- Stochastic Oscillator
- AMBC 17.88
- FTRE 52.12
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.